Found: 26
Select item for more details and to access through your institution.
Letters.
- Published in:
- 2002
- By:
- Publication type:
- Letter
Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial.
- Published in:
- Journal of Bone & Mineral Research, 2013, v. 28, n. 4, p. 746, doi. 10.1002/jbmr.1808
- By:
- Publication type:
- Article
Bone remodeling in postmenopausal women who discontinued denosumab treatment: Off-treatment biopsy study.
- Published in:
- Journal of Bone & Mineral Research, 2011, v. 26, n. 11, p. 2737, doi. 10.1002/jbmr.448
- By:
- Publication type:
- Article
Effects of Denosumab on Bone Histomorphometry: The FREEDOM and STAND Studies.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 10, p. 2256, doi. 10.1002/jbmr.149
- By:
- Publication type:
- Article
Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial.
- Published in:
- Journal of Bone & Mineral Research, 2009, v. 24, n. 1, p. 153, doi. 10.1359/jbmr.0809010
- By:
- Publication type:
- Article
Early Changes in Biochemical Markers of Bone Formation Predict BMD Response to Teriparatide in Postmenopausal Women With Osteoporosis.
- Published in:
- Journal of Bone & Mineral Research, 2005, v. 20, n. 6, p. 962, doi. 10.1359/JBMR.050105
- By:
- Publication type:
- Article
Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.
- Published in:
- 2016
- By:
- Publication type:
- Letter
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 2, p. 394, doi. 10.1210/jc.2010-1805
- By:
- Publication type:
- Article
The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1263, n. 1, p. 29, doi. 10.1111/j.1749-6632.2012.06674.x
- By:
- Publication type:
- Article
Editorial: Beyond Bone Mineral Density-Navigating the Laboratory Assessment of Patients with Osteoporosis.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 10, p. 4429, doi. 10.1210/jc.2002-021310
- By:
- Publication type:
- Article
Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.
- Published in:
- Human Reproduction, 2024, v. 39, n. 3, p. 526, doi. 10.1093/humrep/dead263
- By:
- Publication type:
- Article
Лікування симптомів міоми матки з використанням комбінованої терапії релюголіксом.
- Published in:
- Reproductive Health of Woman, 2024, v. 72, n. 4, p. 53, doi. 10.30841/2708-8731.4.2024.308996
- By:
- Publication type:
- Article
Rationale, objectives and design of the Direct Analysis of Nonvertebral Fracture in the Community Experience (DANCE) Study.
- Published in:
- Osteoporosis International, 2006, v. 17, n. 1, p. 85, doi. 10.1007/s00198-005-1915-3
- By:
- Publication type:
- Article
Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia<sup>®</sup> (denosumab) for the treatment of postmenopausal osteoporosis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2013, v. 22, n. 10, p. 1107, doi. 10.1002/pds.3477
- By:
- Publication type:
- Article
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Modeling‐Based Bone Formation in the Human Femoral Neck in Subjects Treated With Denosumab.
- Published in:
- Journal of Bone & Mineral Research, 2020, v. 35, n. 7, p. 1282, doi. 10.1002/jbmr.4006
- By:
- Publication type:
- Article
Reduction of Cortical Bone Turnover and Erosion Depth After 2 and 3 Years of Denosumab: Iliac Bone Histomorphometry in the FREEDOM Trial.
- Published in:
- Journal of Bone & Mineral Research, 2019, v. 34, n. 4, p. 626, doi. 10.1002/jbmr.3631
- By:
- Publication type:
- Article
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension.
- Published in:
- Journal of Bone & Mineral Research, 2017, v. 32, n. 7, p. 1481, doi. 10.1002/jbmr.3119
- By:
- Publication type:
- Article
Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab.
- Published in:
- Journal of Bone & Mineral Research, 2015, v. 30, n. 7, p. 1280, doi. 10.1002/jbmr.2480
- By:
- Publication type:
- Article
Journal of Bone and Mineral Research: Volume 30, Issue 5, May 2015, Frontmatter page ii.
- Published in:
- Journal of Bone & Mineral Research, 2015, v. 30, n. 7, p. 1347, doi. 10.1002/jbmr.2543
- By:
- Publication type:
- Article
Effects of Up to 5 Years of Denosumab Treatment on Bone Histology and Histomorphometry: The FREEDOM Study Extension.
- Published in:
- Journal of Bone & Mineral Research, 2014, v. 29, n. 9, p. 2051, doi. 10.1002/jbmr.2236
- By:
- Publication type:
- Article